Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Revolution Medicines Inc (NASDAQ: RVMD) closed the day trading at $43.54 down -3.72% from the previous closing price of $45.22. In other words, the price has decreased by -$3.72 from its previous closing price. On the day, 2.87 million shares were traded. RVMD stock price reached its highest trading level at $45.54 during the session, while it also had its lowest trading level at $43.4.
Ratios:
For a better understanding of RVMD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.79 and its Current Ratio is at 11.79. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On September 05, 2025, Truist started tracking the stock assigning a Buy rating and target price of $99.
On August 19, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $75.Piper Sandler initiated its Overweight rating on August 19, 2025, with a $75 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 16 ’25 when Wei Lin sold 2,160 shares for $45.82 per share. The transaction valued at 98,982 led to the insider holds 88,339 shares of the business.
Kelsey Stephen Michael sold 5,367 shares of RVMD for $245,942 on Sep 16 ’25. The insider now owns 284,047 shares after completing the transaction at $45.82 per share. On Sep 16 ’25, another insider, GOLDSMITH MARK A, who serves as the insider of the company, sold 13,411 shares for $45.82 each. As a result, the insider received 614,558 and left with 452,309 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVMD now has a Market Capitalization of 8139070976 and an Enterprise Value of 6134687232.
Stock Price History:
The Beta on a monthly basis for RVMD is 1.25, which has changed by 0.02134645 over the last 52 weeks, in comparison to a change of 0.1653893 over the same period for the S&P500. Over the past 52 weeks, RVMD has reached a high of $62.40, while it has fallen to a 52-week low of $29.17. The 50-Day Moving Average of the stock is 12.66%, while the 200-Day Moving Average is calculated to be 9.25%.
Shares Statistics:
Over the past 3-months, RVMD traded about 2.38M shares per day on average, while over the past 10 days, RVMD traded about 2508510 shares per day. A total of 186.90M shares are outstanding, with a floating share count of 162.02M. Insiders hold about 13.33% of the company’s shares, while institutions hold 91.91% stake in the company. Shares short for RVMD as of 1756425600 were 16527230 with a Short Ratio of 6.94, compared to 1753920000 on 13930629. Therefore, it implies a Short% of Shares Outstanding of 16527230 and a Short% of Float of 9.41.
Earnings Estimates
Investors are keenly observing as 14.0 analysts analyze and rate. The current performance of Revolution Medicines Inc (RVMD) in the stock market.The consensus estimate for the next quarter is -$1.48, with high estimates of -$1.18 and low estimates of -$1.73.
Analysts are recommending an EPS of between -$4.47 and -$5.62 for the fiscal current year, implying an average EPS of -$5.24. EPS for the following year is -$5.81, with 15.0 analysts recommending between -$4.47 and -$7.69.
